• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
 Moderate Pain - Pipeline Review, H2 2013:Industry Analysis Report
 

Moderate Pain - Pipeline Review, H2 2013:Industry Analysis Report

on

  • 363 views

Moderate Pain - Pipeline Review, H2 2013:Industry Analysis Report @ http://www.researchmoz.us/moderate-pain-pipeline-review-h2-2013-report.html

Moderate Pain - Pipeline Review, H2 2013:Industry Analysis Report @ http://www.researchmoz.us/moderate-pain-pipeline-review-h2-2013-report.html

Statistics

Views

Total Views
363
Views on SlideShare
363
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

     Moderate Pain - Pipeline Review, H2 2013:Industry Analysis Report Moderate Pain - Pipeline Review, H2 2013:Industry Analysis Report Document Transcript

    • Moderate Pain - Pipeline Review, H2 2013 Global Markets Directs, 'Moderate Pain Pipeline Review, H2 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Moderate Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Moderate Pain. Moderate Pain Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope A snapshot of the global therapeutic scenario for Moderate Pain. A review of the Moderate Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Coverage of products based on various stages of development ranging from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and combined therapeutics. Coverage of the Moderate Pain pipeline on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Reasons to buy Identify and understand important and diverse types of therapeutics under development for Moderate Pain. Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. Devise corrective measures for pipeline projects by understanding Moderate Pain pipeline depth and focus of Indication therapeutics. Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline. table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 5 introduction 6 global Markets Direct Report Coverage 6 moderate Pain Overview 7 therapeutics Development 8 an Overview Of Pipeline Products For Moderate Pain 8 moderate Pain Therapeutics Under Development By Companies 10 Moderate Pain - Pipeline Review, H2 2013
    • late Stage Products 12 comparative Analysis 12 mid Clinical Stage Products 13 comparative Analysis 13 early Clinical Stage Products 14 comparative Analysis 14 pre-clinical Stage Products 15 comparative Analysis 15 moderate Pain Therapeutics - Products Under Development By Companies 16 companies Involved In Moderate Pain Therapeutics Development 17 nektar Therapeutics 17 esteve Group 18 pain Therapeutics, Inc. 19 pfizer Inc. 20 menarini Group 21 acura Pharmaceuticals, Inc. 22 elite Pharmaceuticals, Inc. 23 charleston Laboratories, Inc. 24 trevena, Inc. 25 qrxpharma Limited 26 kempharm, Inc. 27 theraquest Biosciences, Llc 28 moderate Pain - Therapeutics Assessment 29 assessment By Monotherapy Products 29 assessment By Combination Products 30 assessment By Route Of Administration 31 assessment By Molecule Type 33 drug Profiles 35 pti-202 - Drug Profile 35 product Description 35 mechanism Of Action 35 r&d Progress 35 (oxycodone + Naltrexone) - Drug Profile 36 product Description 36 mechanism Of Action 36 r&d Progress 36 oxycodone Er - Drug Profile 38 product Description 38 mechanism Of Action 38 r&d Progress 38 pti-721 - Drug Profile 40 product Description 40 mechanism Of Action 40 Moderate Pain - Pipeline Review, H2 2013
    • r&d Progress 40 (morphine + Oxycodone) - Drug Profile 41 product Description 41 mechanism Of Action 41 r&d Progress 41 nktr-194 - Drug Profile 43 product Description 43 mechanism Of Action 43 r&d Progress 43 levorphanol Tartrate Er - Drug Profile 44 product Description 44 mechanism Of Action 44 r&d Progress 44 buprenorphine Hydrochloride Er - Drug Profile 45 product Description 45 mechanism Of Action 45 r&d Progress 45 (dexketoprofen Trometamol + Tramadol Hydrochloride) - Drug Profile 46 product Description 46 mechanism Of Action 46 r&d Progress 46 hydromorphone Ir - Drug Profile 47 product Description 47 mechanism Of Action 47 r&d Progress 47 e-58425 - Drug Profile 48 product Description 48 mechanism Of Action 48 r&d Progress 48 hs-731 - Drug Profile 49 product Description 49 mechanism Of Action 49 r&d Progress 49 (promethazine + Hydrocodone + Acetaminophen) - Drug Profile 50 product Description 50 mechanism Of Action 50 r&d Progress 50 (oxycodone Hydrochloride + Naltrexone Hydrochloride) Extended Release - Drug Profile 51 product Description 51 mechanism Of Action 51 r&d Progress 51 trv-734 - Drug Profile 53 product Description 53 Moderate Pain - Pipeline Review, H2 2013
    • mechanism Of Action 53 r&d Progress 53 moderate Pain Therapeutics - Drug Profile Updates 54 moderate Pain Therapeutics - Discontinued Products 58 moderate Pain Therapeutics - Dormant Products 59 moderate Pain - Product Development Milestones 60 featured News & Press Releases 60 sep 10, 2013: Relmada Therapeutics Announces Positive Results Of Levocap Er Pivotal Pharmacokinetic Study 60 jun 26, 2013: Qrxpharma Updates Moxduo Nda Review 60 may 17, 2012: Janssen Presents Phase Iii Study Results Of Nucynta Er Extended-release Tablets At 31st Annual Scientific Meeting Of American Pain Society 61 appendix 63 methodology 63 coverage 63 secondary Research 63 primary Research 63 expert Panel Validation 63 contact Us 64 disclaimer 64 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Moderate Pain - Pipeline Review, H2 2013